Zhiying Liu

Qingdao University — China

Immunology and Microbiology · Life Sciences

15h-index797citations107works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(20), Hepatitis B Virus Studies(16), Virus-based gene therapy research(11), Immune Cell Function and Interaction(10), HIV/AIDS Research and Interventions(8)

Publications106 total

Autosomal dominant tubulointerstitial kidney disease in Chinese patients
Nephrology Dialysis Transplantation·2025
Binary PdCu Nanoparticles for Electrocatalytic Ethanol Oxidation
ACS Applied Nano Materials·2025· 2 cited
Supplementary Data1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure S1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Table 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure 4 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Table 2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure 5 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure S2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Data from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure 2 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure 1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Figure 3 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
2025Open Access
Ischemia-free liver transplantation as a novel approach to improve survival and clinical outcomes in the acute-on-chronic liver failure scenario
American Journal of Transplantation·2025Open Access
Surfactant-Mediated Synthesis of Pd<sub>3</sub>Pb<sub>1</sub> Nanocatalysts toward Ethanol Electrooxidation
ACS Applied Materials & Interfaces·2025· 1 cited
Spin-orbit coupling driven topological transition in p-type thermoelectric KMg4Sb3-Bi : a DFT study
Solid State Sciences·2025Open Access
Solvothermal Synthesis of PdPtCuRhRu High-Entropy Alloy Nanosheets for Advanced Alcohol Oxidation Reactions
Langmuir·2025· 4 cited
Identification of SEC16B as a novel regulator of glucose homeostasis
Diabetologia·2025
HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation
Clinical Cancer Research·2025· 1 citedOpen Access
Bad News Is not Always Bad: The Effect of Negative Coverage on Corporate Ambidextrous Innovation
Academy of Management Proceedings·2025
page 1 of 6Next →

Frequent Co-authors

Bin Su(11), Hao Wu(9), Xiaofan Lu(8), Xiaojie Huang(7), Tong Zhang(5), Jiewen Fu(5), Qi Tan(5), Jiayue He(5), Junjiang Fu(5), Yanmei Jiao(4), Rui Wang(4), Yunxia Ji(4), Wei Xia(4), Dexi Chen(4), Lifeng Liu(4), Jingliang Cheng(4), Yuan Lin(4), Feili Wei(3), Tong Zhang(3), Huan Xia(3)